-
Je něco špatně v tomto záznamu ?
Cluster of hepatitis C in a family: a twenty-year follow-up
Alberto Frosi, Maria Franca Meloni, Giacomo Frosi
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články
Digitální knihovna NLK
Zdroj
NLK
Free Medical Journals
od 2004
ProQuest Central
od 2009-03-01 do Před 6 měsíci
Medline Complete (EBSCOhost)
od 2006-03-01 do Před 6 měsíci
Nursing & Allied Health Database (ProQuest)
od 2009-03-01 do Před 6 měsíci
Health & Medicine (ProQuest)
od 2009-03-01 do Před 6 měsíci
Public Health Database (ProQuest)
od 2009-03-01 do Před 6 měsíci
ROAD: Directory of Open Access Scholarly Resources
od 1993
PubMed
31241295
DOI
10.21101/cejph.a5027
Knihovny.cz E-zdroje
- MeSH
- antivirové látky terapeutické užití MeSH
- chronická hepatitida C krev diagnóza přenos MeSH
- dítě MeSH
- Hepacivirus izolace a purifikace MeSH
- hepatitida C farmakoterapie přenos MeSH
- jaterní cirhóza farmakoterapie MeSH
- lidé MeSH
- následné studie MeSH
- přenos infekční nemoci MeSH
- ribavirin terapeutické užití MeSH
- rodina * MeSH
- společné užívání jehel škodlivé účinky MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
OBJECTIVE: We described an impressive cluster of hepatitis C in a single family. Of nine members of the family, six - the mother and five daughters - were affected by chronic hepatitis, hepatitis C virus (HCV) genotype 1b, of which two were co-infected with hepatitis B virus (HBV). Sharing a non-disposable injection equipment for intramuscular medical care was the most likely route of contagion. Twenty years after the first observation, we performed a follow up of this family. METHODS: The clinical history was updated, and the members of the family underwent a clinical evaluation, extensive liver laboratory tests, and whole serology for hepatitis C and B. Protein chain reaction for HCV RNA was performed when indicated. The eight spouses of the offspring and their eight children underwent the same evaluation. RESULTS: The main findings of this study are the favourable outcome of the two members of the family mono-infected by HCV, treated with peginterferon and ribavirin (sustained response and free of liver disease), in contrast with the ominous outcome of the two members co-infected with HCV and HBV, who evolved to decompensated cirrhosis, with hepatocellular carcinoma in one case, ultimately leading to death. A further feature is the absence of transmission of HCV to the spouses and to the third generation of children of this family, consistent with the assumption that sexual and vertical transmission is unlikely. CONCLUSIONS: A thorough epidemiological investigation of the two first generations of this family, the study of their spouses and children, and the twenty years of follow up provided a strong presumption that the infection with HCV had occurred within this family through the promiscuous use of the same inadequately sterilized glass syringe for intramuscular therapies, as was a common practice during the fifties and sixties worldwide and still is in some part of the world.
Institute of Translational Medicine University of Liverpool Liverpool United Kingdom
Interventional Ultrasound Institute of Care IGEA Milano Italy
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19024828
- 003
- CZ-PrNML
- 005
- 20190801103617.0
- 007
- ta
- 008
- 190704s2019 xr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.21101/cejph.a5027 $2 doi
- 035 __
- $a (PubMed)31241295
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Frosi, Alberto $u IRCCS Multimedica Hospital, Sesto San Giovanni, Italy
- 245 10
- $a Cluster of hepatitis C in a family: a twenty-year follow-up / $c Alberto Frosi, Maria Franca Meloni, Giacomo Frosi
- 520 9_
- $a OBJECTIVE: We described an impressive cluster of hepatitis C in a single family. Of nine members of the family, six - the mother and five daughters - were affected by chronic hepatitis, hepatitis C virus (HCV) genotype 1b, of which two were co-infected with hepatitis B virus (HBV). Sharing a non-disposable injection equipment for intramuscular medical care was the most likely route of contagion. Twenty years after the first observation, we performed a follow up of this family. METHODS: The clinical history was updated, and the members of the family underwent a clinical evaluation, extensive liver laboratory tests, and whole serology for hepatitis C and B. Protein chain reaction for HCV RNA was performed when indicated. The eight spouses of the offspring and their eight children underwent the same evaluation. RESULTS: The main findings of this study are the favourable outcome of the two members of the family mono-infected by HCV, treated with peginterferon and ribavirin (sustained response and free of liver disease), in contrast with the ominous outcome of the two members co-infected with HCV and HBV, who evolved to decompensated cirrhosis, with hepatocellular carcinoma in one case, ultimately leading to death. A further feature is the absence of transmission of HCV to the spouses and to the third generation of children of this family, consistent with the assumption that sexual and vertical transmission is unlikely. CONCLUSIONS: A thorough epidemiological investigation of the two first generations of this family, the study of their spouses and children, and the twenty years of follow up provided a strong presumption that the infection with HCV had occurred within this family through the promiscuous use of the same inadequately sterilized glass syringe for intramuscular therapies, as was a common practice during the fifties and sixties worldwide and still is in some part of the world.
- 650 _2
- $a antivirové látky $x terapeutické užití $7 D000998
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a přenos infekční nemoci $7 D018562
- 650 12
- $a rodina $7 D005190
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a následné studie $7 D005500
- 650 _2
- $a Hepacivirus $x izolace a purifikace $7 D016174
- 650 _2
- $a hepatitida C $x farmakoterapie $x přenos $7 D006526
- 650 _2
- $a chronická hepatitida C $x krev $x diagnóza $x přenos $7 D019698
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a jaterní cirhóza $x farmakoterapie $7 D008103
- 650 _2
- $a společné užívání jehel $x škodlivé účinky $7 D016485
- 650 _2
- $a ribavirin $x terapeutické užití $7 D012254
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Meloni, Maria Franca $u Interventional Ultrasound, Institute of Care IGEA, Milano, Italy
- 700 1_
- $a Frosi, Giacomo $u Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom
- 773 0_
- $w MED00001083 $t Central European journal of public health $x 1210-7778 $g Roč. 27, č. 2 (2019), s. 170-172
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31241295 $y Pubmed
- 910 __
- $a ABA008 $b B 1829 $c 562 $y 4 $z 0
- 990 __
- $a 20190704 $b ABA008
- 991 __
- $a 20190801081046 $b ABA008
- 999 __
- $a ok $b bmc $g 1428373 $s 1063246
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 27 $c 2 $d 170-172 $e - $i 1210-7778 $m Central European Journal of Public Health $n Cent. Eur. J. Public Health $x MED00001083
- LZP __
- $b NLK111 $a Pubmed-20190704